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Penile metastasis of renal cell carcinoma is a rare occurrence. We report a case in a 44-year-old man who
presented with malignant priapism as the ﬁrst sign of recurrence of renal cell carcinoma. Although
invasive procedures have a limited role in survival beneﬁts, we performed a total penectomy to alleviate
pain and provide a better quality of life.
Copyright  2014, Taiwan Urological Association. Published by Elsevier Taiwan LLC.
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Penile metastasis of renal cell carcinoma (RCC) is a rare occur-
rence and indicates a poor prognosis. In this report, we describe a
44-year-old man with a history of left side RCC status postradical
nephrectomy who presented with priapism as the ﬁrst sign of
cancer recurrence.2. Case report
The patient was a 44-year-old Asian man, who was initially
diagnosed with left side RCC (clear cell, stage IV with evidence of
liver metastasis) in 2011 in Germany. He had undergone a left
radical nephrectomy 1 month after diagnosis and had been taking
sunitinib since the operation. Seven months after his operation, he
complained of increasing penile pain and persistent rigidity of his
penis which was not elicited by sexual stimulation. He did not
complain of any urinary symptoms. There was no history of any
recent trauma. Corporeal cavernosal aspiration and intracavernosal
phenylephrine injection did not provide relief. Oral narcotics were
also not effective for pain. Because of persistent and intractableBuddhist Tzu Chi General
Yang Road, Hualien, Taiwan.
ciation. Published by Elsevier Taiwpain which impaired his activities of daily living, he was brought to
our hospital for a second opinion.
On examination, his penis was erect and the shaft was swollen
(Fig. 1A). There was a small brown eschar on the glans with sur-
rounding erythema. The penis was extremely rigid and tender on
palpation. An indurated nodule was palpated on the body of the
penis. A rectal examination of the patient revealed a benign-feeling
prostate. A urinalysis showed no abnormalities. Magnetic reso-
nance imaging (MRI) showed a heterogeneous mass in the entire
penile shaft with both the corpus cavernosum and spongiosum
replaced by a tumor (Fig. 1B). An open biopsy indicated metastatic
RCC. Subsequent computed tomography of the abdomen to the
pelvis demonstrated metastatic disease in the liver, para-aortic
lymph nodes, and probably the lumbar spine. Because of intrac-
table pain and the need for high-dose narcotics, a palliative total
penectomy with perineal urethrostomy was performed.
The penile shaft was grayish-white and ﬁrm, and the prepuce
was ulcerated. On cutting, multifocal grayish homogenous areas
were noted vertically along the segment of the specimen. The
lumen of the urethra showed no evidence of tumor invasion.
Moderately differentiated clear cell RCC with lymphovascular and
perineural invasion was seen microscopically (Fig. 2). Immuno-
chemistry with cytokeratin was used to conﬁrm the presence of
metastatic RCC (Fig. 3). The patient’s postoperative course was
uneventful. The wound healed satisfactorily and free of infection.
Prior to the patient’s discharge, his pain was reasonably managed
with only oral nonopioid analgesics.an LLC. Open access under CC BY-NC-ND license.
Fig. 1. (A) Examination showed a painful erect penis which was refractory to corporeal cavernosal aspiration and intracavernosal phenylephrine injection; (B) magnetic resonance
imaging, sagittal view, showed that both the corpus cavernosum and spongiosum were replaced by a heterogeneous mass.
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RCC is one of the most common malignancies arising from the
genitourinary tract, accounting for 3% of adult malignancies in AsianFig. 2. Moderately differentiated clear cell RCC with lymphovascular (stapopulations.1 Approximately 30% of the patients with RCC have
metastatic disease at the time of diagnosis. The most common met-
astatic sites are the lung, liver, bone, ipsilateral lymph nodes, and
adrenal glands. RCC with penile metastasis is, however, anrs) and perineural invasion (arrow) was conﬁrmed microscopically.
Fig. 3. Immunohistochemical staining with cytokeratin was used to conﬁrm the presence of metastatic RCC. The blue arrow indicates perineural invasion.
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than 50 cases of penile metastasis from renal cell carcinoma have
been reported in the English literature.2,3 The mean age at diagnosis,
in most cases, is the 60s which represents the common age-related
incidence of primary malignancy.3 Our patient is perhaps the youn-
gest reported patient with this uncommon condition.
Secondary malignancy of the penis from metastatic disease was
ﬁrst described by Eberth in 1870 and 504 cases have been reported
worldwide since then. Of these, 63.9%weremetastatic lesions arising
from the genitourinary tract (bladder: 28.6%, prostate: 27.9%, kidney:
6.9%, andureter: 0.5%),with colorectal adenocarcinoma, carcinomaof
the respiratory tract, melanoma, and hematologic diseases
comprising the rest.2 Clinical manifestations of penile metastases
may include indurated nodules, penile masses, skin lesions, or
commonly, malignant priapism which is estimated to occur in 20e
50% of patients.2e4 In this case, priapism developed 7 months after
nephrectomy in our patient as the ﬁrst sign of cancer recurrence.
Malignant priapism is deﬁned as a persistent, painful, and nonsexual
erection, probably caused by tumor cells invading the cavernosal si-
nuses and associated venous system or continual stimulation of the
erectile afferent and/or efferent neural pathways.5 Urinary symptoms
(for example, incontinence, hematuria, irritative/obstructive symp-
toms, etc.) are among the most frequently reported features by pa-
tients with priapism and renal malignancy.3 This phenomenon,
oddly, was not observed in our patient.
Although a few hypotheses have been proposed to explain how
primary malignant cells reach the penis, the actual mechanism
remains unknown. The most accepted current theory is that spread
of renal neoplastic cells to the penis may involve retrograde venous
and lymphatic ﬂow and/or antegrade arterial dissemination.2,3 On
both the macroscopic and microscopic level, both the corpora
cavernosa and corpus spongiosum were extensively replaced by
RCC in our patient. Thrombi formation in the arterial system was
also in evidence as well as lymphovascular and perineural invasion.
Given its rarity and similar clinical presentations, secondary
penile cancer is often misdiagnosed initially as infective diseases,
Peyronie’s disease, or nonmalignant priapism, which results in
delayed treatment. Patients with a strong family history or previous
history of cancer who present with priapism or a penile mass must
be investigated thoroughly.2 Penile duplex Doppler ultrasoundmay
be of value in evaluation of malignant priapism by distinguishing
between high-ﬂow and low-ﬂow status.5 Although deﬁnite diag-
nosis of penile metastasis is made by either biopsy or intra-
corporeal aspiration, CT and MRI are also considered to be reliable
and noninvasive in conﬁrming the diagnosis and determining the
extent of the disease.6Generally speaking, survival among these patients is poor, as
invasion of the penis by metastatic tumor usually represents con-
current disseminated disease. There are various treatment modal-
ities available and these should be tailored according to the clinical
scenario. Radiotherapy, chemotherapy, and brachytherapy are also
implied to control disease progression but have not been shown to
improve survival.2 Conservative treatment or symptomatic treat-
ment could be a reasonable choice for malignant priapism because
of the relatively short life expectancy of the patients. As described
by literature, dorsal nerve section, excision of the corpora cav-
ernosa, or total penectomy have been reported to be effective in
cases of intractable pain.2 As mentioned earlier, penile metastasis is
associated with advanced disease. Despite aggressive treatment,
the average survival in patients with metastatic RCC is no longer
than 10 months.7 Total penectomy may pose psychological trau-
matic experience to patients, but in this case, the patient’s symp-
toms (mainly pain) were considerably reduced and had the
freedom to return to near premorbid state. Although it is likely that
such an invasive procedure has very limited survival beneﬁts, the
patient at least has a better quality of life.
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